Novel Chinese patent medicine for benefiting heart and diminishing swelling

Abstract

The invention discloses a novel Chinese patent medicine for benefiting heart and diminishing swelling. The novel Chinese patent medicine is prepared from the following raw materials in parts by weight: 20-30 parts of lumbricus, 12-18 parts of pinellia tuber, 12-25 parts of Gan-oderma applanatum (Pers. Ex Wallr) Pat., 15-25 parts of figwort root, 15-25 parts of Mongolian snake gourd, 15-20 parts of human hair, 10-18 parts of fritillary and 15-20 parts of white mulberry root-bark. The novel Chinese patent medicine has the advantages that the cure rate is higher, the cardiac pumping function is improved and the myocardial viability is improved compared with existing heart drugs, relieves symptoms of heart diseases in a short time and has obvious curative effects; using various traditional Chinese medicine ingredients together, the novel Chinese patent medicine achieves the effects of clearing away heat and toxic materials, activating blood circulation to dissipate stasis, dispelling cold and clearing tendons, invigorating channels and pulse-beat and removing dampness to stop pains; the novel Chinese patent medicine is scientific in compatibility, achieves curative effects quickly and has the advantages of high effect taking speed, short course of treatment and low cost towards myocardial ischemia and angina caused by heart diseases.

Description

technical field [0001] The invention relates to a novel Chinese patent medicine for promoting the heart and reducing swelling, which belongs to the field of traditional Chinese medicine. Background technique [0002] Heart disease is the general term for heart disease, including rheumatic heart disease, congenital heart disease, hypertensive heart disease, coronary heart disease, myocarditis and other heart diseases. Among them, rheumatic heart disease accounts for the first few in the number of hospitalized heart disease patients. Rheumatic fever is an acute or chronic systemic allergic connective tissue disease that mainly invades the heart and joints and is prone to relapse. Its clinical features are migratory polyarthritis, carditis, erythema annulare, chorea, etc. After acute or repeated attacks, obvious heart damage is often left over, especially the damage of heart valves, which eventually forms rheumatic heart valve disease, i.e. rheumatic heart disease. Rheumatic ...

AI Technical Summary

Problems solved by technology

At present, surgical treatment is mostly performed, including closed or direct-view mitral valve separation and mitral valve replacement. Although the curative effect is definite, thoracotomy is traumatic, and there is a certain risk and mortality, and the patient suffers a lot. The cost is high, so it is not easy for patients to accept